Fig. 1From: Imaging the TGFβ type I receptor in pulmonary arterial hypertensionMolecular structures of the ALK5 targeting PET tracers, [18F]EW-7197 and [11C]LR111, and the selective ALK5 kinase inhibitor SB431542Back to article page